Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathogenetic potential of antiphospholipid antibodies.

× No keyword cloud information.

15 in total

1. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

Authors: R Cervera; J Font; A López-Soto; F Casals; L Pallarés; A Bové; M Ingelmo; A Urbano-Márquez
Journal: Ann Rheum Dis Date: 1990-02 Impact factor: 19.103

2. Histopathological findings in a case of systemic lupus erythematosus-associated anti-phospholipid syndrome.

Authors: P L Meroni; R Rivolta; P Ghidoni
Journal: Clin Rheumatol Date: 1991-06 Impact factor: 2.980

3. Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.

Authors: H J Out; M van Vliet; P G de Groot; R H Derksen
Journal: Ann Rheum Dis Date: 1992-03 Impact factor: 19.103

Review 4. The antiphospholipid antibody dilemma.

Authors: R H Derksen; P Hasselaar; J D Oosting; P G De Groot
Journal: Clin Rheumatol Date: 1990-03 Impact factor: 2.980

5. Disseminated zygomycosis and systemic lupus erythematosus.

Authors: C A Bloxham; S Carr; D W Ryan; P J Kesteven; R S Bexton; I D Griffiths; J Richards
Journal: Intensive Care Med Date: 1990 Impact factor: 17.440

6. Superficial migratory thrombophlebitis in a patient with reversible protein C deficiency and anticardiolipin antibodies.

Authors: C Fiehn; A Pezzutto; W Hunstein
Journal: Ann Rheum Dis Date: 1994-12 Impact factor: 19.103

Pathogenetic potential of antiphospholipid antibodies.

1. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

2. Histopathological findings in a case of systemic lupus erythematosus-associated anti-phospholipid syndrome.

3. Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.

Review 4. The antiphospholipid antibody dilemma.

5. Disseminated zygomycosis and systemic lupus erythematosus.

6. Superficial migratory thrombophlebitis in a patient with reversible protein C deficiency and anticardiolipin antibodies.

7. Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus.

8. Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations.

9. A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE).

10. Findings at necropsy in the heart of a patient with anticardiolipin syndrome.